These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TRA AND Treatment
21 results:

  • 1. A Novel JAK2 Fusion in T-Cell Prolymphocytic leukemia.
    Eren OC; Stuver R; Zhou T; Zaidinski M; Moskowitz AJ; Horwitz SM; Ewalt MD; Zhang Y; Lim MS
    Genes Chromosomes Cancer; 2024 Jun; 63(6):e23252. PubMed ID: 39133763
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk Factors for treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
    Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
    J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
    [No Abstract]    [Full Text] [Related]  

  • 3. trametinib enhances Atra-induced differentiation in AML cells.
    Lu H; Li ZY; Ding M; Liang C; Weng XQ; Sheng Y; Wu J; Cai X
    Leuk Lymphoma; 2021 Dec; 62(14):3361-3372. PubMed ID: 34355652
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chromosome translocation t(14;21)(q11;q22) Activates Both
    Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
    Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies.
    Komkov A; Miroshnichenkova A; Nugmanov G; Popov A; Pogorelyy M; Zapletalova E; Jelinkova H; Pospisilova S; Lebedev Y; Chudakov D; Olshanskaya Y; Plevova K; Maschan M; Mamedov I
    Br J Haematol; 2020 Mar; 188(5):723-731. PubMed ID: 31587259
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors.
    Nijenhuis CM; Hellriegel E; Beijnen JH; Hershock D; Huitema AD; Lucas L; Mergui-Roelvink M; Munteanu M; Rabinovich-Guilatt L; Robertson P; Rosing H; Spiegelstein O; Schellens JH
    Invest New Drugs; 2016 Oct; 34(5):565-74. PubMed ID: 27221729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature.
    Dyba J; Tinmouth A; Bredeson C; Matthews J; Allan DS
    Transfus Med; 2016 Jun; 26(3):202-7. PubMed ID: 27046441
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of differentiating agents on interferon-gamma (INF-gamma) level in leukemic cells propagated ex-vivo.
    El-Houseini ME; Amer IR; Hussein TD
    J Egypt Natl Canc Inst; 2006 Dec; 18(4):283-91. PubMed ID: 18301452
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
    Zhang Y; Dawson MI; Ning Y; Polin L; Parchment RE; Corbett T; Mohamed AN; Feng KC; Farhana L; Rishi AK; Hogge D; Leid M; Peterson VJ; Zhang XK; Mohammad R; Lu JS; Willman C; VanBuren E; Biggar S; Edelstein M; Eilender D; Fontana JA
    Blood; 2003 Nov; 102(10):3743-52. PubMed ID: 12893763
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia.
    Jing Y; Xia L; Waxman S
    Blood; 2002 Aug; 100(3):1008-13. PubMed ID: 12130515
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.
    Puccetti E; Sennewald B; Fosca-Ferrara F; Boehrer S; Bianchini A; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Hematol J; 2001; 2(6):385-92. PubMed ID: 11920278
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.
    Jing Y; Wang L; Xia L; Chen GQ; Chen Z; Miller WH; Waxman S
    Blood; 2001 Jan; 97(1):264-9. PubMed ID: 11133770
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.
    Raelson JV; Nervi C; Rosenauer A; Benedetti L; Monczak Y; Pearson M; Pelicci PG; Miller WH
    Blood; 1996 Oct; 88(8):2826-32. PubMed ID: 8874178
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.
    Jiang SY; Shyu RY; Chen HY; Lee MM; Wu KL; Yeh MY
    Oncology; 1996; 53(4):334-40. PubMed ID: 8692540
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
    Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 28-kDa mammalian heat shock protein, a novel substrate of a growth regulatory protease involved in differentiation of human leukemia cells.
    Spector NL; Hardy L; Ryan C; Miller WH; Humes JL; Nadler LM; Luedke E
    J Biol Chem; 1995 Jan; 270(3):1003-6. PubMed ID: 7836350
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
    Skotnicki AB; Stoch A; Sacha T; Nowak WS
    Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Basophilic differentiation in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Snower D; Rubin CM; Reisel H; Variakojis D
    Leukemia; 1993 Apr; 7(4):521-6. PubMed ID: 7710454
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Dulaney AM; Murgatroyd RJ
    Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 2.